NEW YORK ( TheStreet) -- Bio-Reference Labs (Nasdaq: BRLI) hit a new 52-week high Tuesday as it is currently trading at $26.04, above its previous 52-week high of $25.95 with 114,186 shares traded as of 3:09 p.m. ET. Average volume has been 230,300 shares over the past 30 days. Bio-Reference has a market cap of $704.3 million and is part of the health care sector and health services industry. Shares are up 56.4% year to date as of the close of trading on Monday. Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company has a P/E ratio of 19.1, below the average health services industry P/E ratio of 19.3 and above the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!